Cargando…

The increased cardiovascular risk in rheumatoid arthritis: when does it start?

Established rheumatoid arthritis (RA) is associated with a doubled cardiovascular risk. However, data about the cardiovascular risk in early RA are scarce. Preclinical atherosclerosis can be reliably assessed with the carotid intima media thickness (cIMT), and the cIMT is a well-validated predictor...

Descripción completa

Detalles Bibliográficos
Autor principal: Nurmohamed, Michael T
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990993/
https://www.ncbi.nlm.nih.gov/pubmed/20887640
http://dx.doi.org/10.1186/ar3126
_version_ 1782192538122190848
author Nurmohamed, Michael T
author_facet Nurmohamed, Michael T
author_sort Nurmohamed, Michael T
collection PubMed
description Established rheumatoid arthritis (RA) is associated with a doubled cardiovascular risk. However, data about the cardiovascular risk in early RA are scarce. Preclinical atherosclerosis can be reliably assessed with the carotid intima media thickness (cIMT), and the cIMT is a well-validated predictor of cardiovascular events. The cIMT was therefore used in a recent controlled, prospective study in patients with early RA. Surprisingly, an increased cardiovascular risk at baseline could not be demonstrated whereas cIMT progression appeared to be comparable with the general population. Obviously, this study underscores the need for further large-scale investigations to solve the emerging discrepancy with the existing literature.
format Text
id pubmed-2990993
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29909932011-03-29 The increased cardiovascular risk in rheumatoid arthritis: when does it start? Nurmohamed, Michael T Arthritis Res Ther Editorial Established rheumatoid arthritis (RA) is associated with a doubled cardiovascular risk. However, data about the cardiovascular risk in early RA are scarce. Preclinical atherosclerosis can be reliably assessed with the carotid intima media thickness (cIMT), and the cIMT is a well-validated predictor of cardiovascular events. The cIMT was therefore used in a recent controlled, prospective study in patients with early RA. Surprisingly, an increased cardiovascular risk at baseline could not be demonstrated whereas cIMT progression appeared to be comparable with the general population. Obviously, this study underscores the need for further large-scale investigations to solve the emerging discrepancy with the existing literature. BioMed Central 2010 2010-09-29 /pmc/articles/PMC2990993/ /pubmed/20887640 http://dx.doi.org/10.1186/ar3126 Text en Copyright ©2010 BioMed Central Ltd
spellingShingle Editorial
Nurmohamed, Michael T
The increased cardiovascular risk in rheumatoid arthritis: when does it start?
title The increased cardiovascular risk in rheumatoid arthritis: when does it start?
title_full The increased cardiovascular risk in rheumatoid arthritis: when does it start?
title_fullStr The increased cardiovascular risk in rheumatoid arthritis: when does it start?
title_full_unstemmed The increased cardiovascular risk in rheumatoid arthritis: when does it start?
title_short The increased cardiovascular risk in rheumatoid arthritis: when does it start?
title_sort increased cardiovascular risk in rheumatoid arthritis: when does it start?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990993/
https://www.ncbi.nlm.nih.gov/pubmed/20887640
http://dx.doi.org/10.1186/ar3126
work_keys_str_mv AT nurmohamedmichaelt theincreasedcardiovascularriskinrheumatoidarthritiswhendoesitstart
AT nurmohamedmichaelt increasedcardiovascularriskinrheumatoidarthritiswhendoesitstart